TIDMAG99 TIDMGSK

RNS Number : 3404M

GlaxoSmithKline Capital PLC

07 May 2020

Issued: 7 May 2020, London UK - LSE Announcement

Publication of Final Terms

The following final terms dated 7 May 2020 (the "Final Terms") in respect of the Notes (as defined below) are available for viewing:

GlaxoSmithKline Capital plc issue of:

GBP 750,000,000 1.250 per cent. Notes due 12 October 2028;

GBP 750,000,000 1.625 per cent. Notes due 12 May 2035; and

EUR 750,000,000 0.125 per cent. Notes due 12 May 2023,

in each case guaranteed by GlaxoSmithKline plc issued under the GBP20,000,000,000 Euro Medium Term Note Programme (the "Notes")

Copies of the Final Terms have been submitted to the UK Listing Authority's NSM submission portal via the Electronic Submission System (ESS). A copy can be viewed at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

GlaxoSmithKline Capital plc

980 Great West Road

Brentford

Middlesex

TW8 9GS

United Kingdom

Enquiries:

 
 UK Media enquiries:          David Mawdsley     (020) 8047 5564 
   Simon Steel                                    (020) 8047 3763 
 European Analyst/Investor 
  enquiries:                  James Dodwell      (020) 8047 2406 
   Danielle Smith                                 (020) 8047 0932 
 

BASIS ON WHICH YOU MAY ACCESS THE FINAL TERMS AND BASE PROSPECTUS

Please note that the information contained in the Final Terms and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Final Terms or the Base Prospectus you must ascertain from the Base P rospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirements.

 
 GlaxoSmithKline plc 
  Registered in England & Wales: 
  No. 3888792 
 
 Registered Office: 
  980 Great West Road 
  Brentford, Middlesex 
  TW8 9GS 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

PFTBLGDUCXGDGGR

(END) Dow Jones Newswires

May 07, 2020 12:43 ET (16:43 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Gsk.